🇺🇸 FDA
Patent

US 9273047

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

granted A61KA61K31/4745A61K31/497

Quick answer

US patent 9273047 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377